Increasing Prevalence of Chronic Disorders and Approval and Launch of New Products to Augment Growth of Medical Membrane Market

 

Medical Membrane Market

Advancements in medical sciences, rising incidences of fatal diseases, improvement in medical technology, growth in pharmaceutical and medical industry, increased demand for safe medicines and pharmaceutical products are some of the major driving forces that are expected to drive the medical membrane industry for hematological application and other pharmaceutical purification process.

Medical membranes, which help to safeguard different biological resources are extremely important as they help in protecting our health from various deadly and contagious diseases. These applications include the manufacturing of customized biocompatible solutions for the protection and purification of biological fluids. This industry is witnessing an exponential growth with constant inflow of pharmaceutical products, research and development activities. As per the statistics, there has been a steady rise in the demand for medical devices, materials and equipment that are required for the purification of medicines. With the right purification procedure, the drugs present in the body can remain active and the harmful chemicals out of the system can be avoided.

Market Dynamics

Increasing prevalence of chronic disorders is expected to propel growth of the global medical membrane market. For instance, according to the study, ‘Risk Factors and Rate of Progression of CKD in Children’, published in June 2019 in Kidney International Reports, 38% children experienced progression of chronic kidney disease within 2 years of follow-up.

The global medical membrane market is witnessing several M&A activities. For instance, in December 2020, Collagen Matrix, Inc., a regenerative, collagen-based, xenograft-derived medical devices provider, acquired Sunstar's Degradable Solutions division including its GUIDOR branded line of resorbable synthetic medical implants. Similarly, in January 2021, Blue Earth Diagnostics, a Bracco company, signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in radiopharmaceuticals and radiopharmaceutical technologies, and the Technical University of Munich, to acquire exclusive, worldwide rights to therapeutic applications of novel radiohybrid Prostate-Specific Membrane Antigen technology in prostate cancer.

Among regions, North America is expected to witness significant growth in the global medical membrane market, owing to high prevalence of cancer in the region. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Competitive Analysis

Major players operating in the global medical membrane market include, Nipro Corporation, Amniox, Pall Corporation, Sorin Group, Gore, OXGENE, Maquet Company, Merck Millipore, and others.

Major players operating in the global medical membrane market are focused on approval and launch of new products to expand their product portfolio. For instance, in January 2021, OXGENE, a biotechnology company offering integrated discovery and manufacturing technologies to the cell and gene therapy industry, launched its self-labelling integral membrane (SLIM) protein discovery system.


Comments

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

The market for ureteral stents would benefit from the rising prevalence of urological diseases

The North America Vision Care Market Is Driven by the Increasing Prevalence of Eye Diseases in this Region